No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs138768215 |
chr3:112928619-112928620 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs557221314 |
chr3:112928620-112928621 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs368620735 |
chr3:112928632-112928633 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs12635028 |
chr3:112928656-112928657 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
5 |
rs576777348 |
chr3:112928690-112928691 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs76342564 |
chr3:112928695-112928696 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs7639036 |
chr3:112928762-112928763 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs551087880 |
chr3:112928782-112928783 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs540296038 |
chr3:112928796-112928797 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs565245122 |
chr3:112928848-112928849 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs148963338 |
chr3:112928856-112928857 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs550940586 |
chr3:112928859-112928860 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs569523271 |
chr3:112928880-112928881 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs528753256 |
chr3:112928885-112928886 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs548976199 |
chr3:112928888-112928889 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs79535837 |
chr3:112928913-112928914 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs547321105 |
chr3:112929014-112929015 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs143119201 |
chr3:112929016-112929017 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs73235124 |
chr3:112929032-112929033 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
20 |
rs142885762 |
chr3:112929035-112929036 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs10934227 |
chr3:112929036-112929037 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs200402094 |
chr3:112929058-112929059 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs200128512 |
chr3:112929072-112929073 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs7641396 |
chr3:112929075-112929076 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs555674291 |
chr3:112929076-112929077 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs200989756 |
chr3:112929079-112929080 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs139082119 |
chr3:112929087-112929088 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs138761748 |
chr3:112929091-112929092 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs537775891 |
chr3:112929107-112929108 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs575475495 |
chr3:112929159-112929160 |
Enhancers Weak transcription Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs542485924 |
chr3:112929312-112929313 |
Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs11715505 |
chr3:112929334-112929335 |
Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs376163572 |
chr3:112929359-112929360 |
Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs77045306 |
chr3:112929363-112929364 |
Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs540236648 |
chr3:112929364-112929365 |
Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs546050851 |
chr3:112929377-112929378 |
Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs565375148 |
chr3:112929420-112929421 |
Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs557692069 |
chr3:112929421-112929422 |
Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs532538506 |
chr3:112929479-112929480 |
Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs13070573 |
chr3:112929574-112929575 |
Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs4364141 |
chr3:112929617-112929618 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs7641880 |
chr3:112929621-112929622 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
43 |
rs113974038 |
chr3:112929669-112929670 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs7642061 |
chr3:112929748-112929749 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs567177808 |
chr3:112929749-112929750 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs528042747 |
chr3:112929762-112929763 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs546321861 |
chr3:112929814-112929815 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs76538338 |
chr3:112929831-112929832 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs538384613 |
chr3:112929833-112929834 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs67668649 |
chr3:112929836-112929837 |
Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers
|
TF binding regionCpG islandChromatin interactive region
|
3 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|